The Western European Percutaneous Coronary Intervention (PCI) Devices market is in a mature stage. With minimally invasive technology becoming a well-established treatment for coronary artery diseases in Europe, several product segments such as angioplasty balloons, catheters, and stents are approaching market saturation. Increase in the number of cardiovascular patients is expected because of the ageing population and sedentary lifestyle, thus driving the PCI market. However, market maturity and competitive pricing, leading to price erosion, are undermining market growth. This highly competitive PCI market is expected to pave way for new entrants possessing advanced technology.